Acute Myeloid Leukemia

Most typical Kinds regarding Cancer is Myelogenous Leukemia. Leukemia can be described such as situation of irregular raise of white blood cells created by the bone marrow as well as/or the very lymphatic mechanism. Based upon the cancerous Granulocytes or possibly lymphocytes, leukemia will be categorized onto lymphoblastic leukemia or myelogenous .

Continue reading “Acute Myeloid Leukemia” »

 

Platelet Antibody

Platelets Antibody test is used to evaluate Thrombocytopenia and exclude an immune-associated etiology.

 

Immune-mediated destruction of platelets may be caused by either autoantibodies directed against antigens located on the same person’s platelets or alloantibodies that develop after exposure to transfused platelets received from a donor. These antibodies are usually directed to an antigen on the platelet membrane, such as human leukocyte antigen (HLA) or platelet-specific antigen (e.g., PLA1, PLA2). Many different laboratory techniques can be used to demonstrate the antiplatelet antibodies. These tests can directly identify the immunoglobulin with the use of radioimmunoassay (RIA) or immunofluorescence. Quantitative measurements are possible with cytofluorometry. Other tests identify complement binding on the affected platelet membrane. Most antiplatelet antibody testing is now performed using immunologic assays.

Continue reading “Platelet Antibody” »

 

Leukemia Symptoms and Signs

Leukemia is a universal phrase for several different kinds associated with blood cancer. There are a couple of kinds of acute leukemia and a couple of kinds of chronic leukemia. It starts in the bone marrow when one cell transforms and grows into a leukemia cell. This specific cell increases and ultimately the regular blood cells tend to be congested out. The unnatural cells then leak through the blood and might also conquer the central nervous system.

Continue reading “Leukemia Symptoms and Signs” »

 

Neutrophil Antibody Screen

Neutrophil Antibodies are antibodies produced by human body in order to fight foreign White Blood Cells (WBCs). Neutrophil Antibodies attack all types of White Blood Cells and their engagement is not limited Neutrophils only. Neutrophil Antibodies are given this name since the majority of White Blood Cells are Neutrophils and to avoid any misunderstand of using the term “WBC Antibodies” which would mean the antibodies found normally on the surface of White Blood Cells.

 

Where would foreign White Blood Cells come from? You may ask yourself. They come from blood transfusion procedures. Human immune system considers White Blood Cells that have incompatible Human Lymphocyte as foreign microorganisms and it starts producing Neutrophil Antibodies to protect the body from those foreign WBCs.

Continue reading “Neutrophil Antibody Screen” »

 

HLA-B27 Antigen Testing

Human Lymphocyte Antigens (HLAs) present the Major Histocompatability Complex of human. Testing HLAs is important to indicate tissue compatibility with tissue transplantation. If the HLA antigens of the donor are not compatible with the recipient, the recipient will make antibodies to those antigens, accelerating rejection. Survival of the transplanted tissue is increased if HLA matching is good. Prior HLA sensitization causes antibodies to form in the blood of a transplant recipient and shortens the survival of red blood cells (RBCs) or platelets when transfused.

Continue reading “HLA-B27 Antigen Testing” »

 

Beta-2 Microglobulin

Beta2 Microglobulin is a protein that exists on the surface of all nucleated cells including White Blood CellsBeta2 Microglobulin is a human leukocyte antibody (HLA) major histocompatibility antigen that exists with increased numbers on white blood cells (WBCs) and particularly on lymphatic cells. Production of this protein is increased as these cells are produced or destroyed. Therefore, β2M are increased in patients with malignancies (especially lymphoma, leukemia, or multiple myeloma) or in patients with chronic severe inflammatory diseases. Because the degree of elevation can be related to tumor cell load, β2M is an accurate measurement of tumor disease activity, stage of disease, and prognosis. In that light, it is an important tumor marker. When central nervous system (CNS) involvement with these neoplasms is suspected, β2M can be measured in the CNS fluid and compared to blood levels. Increased levels are diagnostic of CNS involvement.

Continue reading “Beta-2 Microglobulin” »

 

Neutrophil Gelatinase–Associated Lipocalin

There are no early markers for acute or chronic renal disease. Serum creatinine levels rise only after there has been significant renal impairment and injury. It is important to note that the earlier renal disease or injury is identified, the more successfully it can be treated. Early treatment also helps to lower the morbidity associated with the disease. This is particularly important in patients who have serious nonrenal disease (e.g., heart surgery, renal transplant, sepsis). In these patients, severe acute kidney injury (AKI) increases morbidity and mortality of hospitalized patients.

Continue reading “Neutrophil Gelatinase–Associated Lipocalin” »

 

Lactoferrin

Lactoferrin is a glycoprotein expressed by activated neutrophils. The detection of lactoferrin in a fecal sample therefore serves as a surrogate marker for inflammatory white blood cells (WBCs) in the intestinal tract. WBCs in the stool are not stable and may be easily destroyed by temperature changes, delays in testing, and toxins within the stool. As a result, WBCs may not be detected by common microscopic methods. Lactoferrin assay has allowed the identification of inflammatory cells in the stool without the use of microscopy.

Continue reading “Lactoferrin” »

 

Complement Assay

Serum complement is a group of globulin proteins that act as enzymes. These enzymes facilitate the immunologic and inflammatory response. The complement system is important for destroying foreign cells and isolating “foreign” antigens. The total complement, sometimes labeled CH50, is made up of nine major components, C1 through C9. Besides these major components, there are some subcomponents and “inhibitor” components involved in the system. Classic complement activation starts when an immunoglobulin (Ig) M or IgG antibody binds with the C1 q subcomponent of C1. C1 activates C4, which activates C2 and so on to C9. There are also alternative pathways for the activation of this system.

Continue reading “Complement Assay” »